Hs 939.THomo sapiens (Human)Cancer cell line

Also known as: HS939T, Hs939T, Hs939-T, HS-939-T, Hs-939-T

🤖 AI SummaryBased on 3 publications

Quick Overview

Human cell line for cancer research

Detailed Summary

Hs 939.T is a human cell line used in cancer research. It is derived from a tumor and is utilized for studying various aspects of cancer biology, including genetic mutations and drug sensitivity. The cell line is part of the Cancer Cell Line Encyclopedia (CCLE) and has been used in studies related to drug response and genetic profiling. Research on this cell line has contributed to understanding the molecular mechanisms of cancer and the development of targeted therapies.

Research Applications

Cancer researchDrug sensitivity studiesGenetic profiling

Key Characteristics

Part of the Cancer Cell Line Encyclopedia (CCLE)Used in studies of drug response and genetic mutations
Generated on 6/16/2025

Basic Information

Database IDCVCL_1036
SpeciesHomo sapiens (Human)

Donor Information

Age24
Age CategoryAdult
SexFemale
Racecaucasian

Disease Information

DiseaseMelanoma
LineageSkin
SubtypeMelanoma
OncoTree CodeMEL

DepMap Information

Source TypeATCC
Source IDACH-000814_source

Known Sequence Variations

TypeGene/ProteinDescriptionZygosityNoteSource
MutationSimpleCDKN2Ap.Arg58Ter (c.172C>T) (p.Pro72Leu, c.215C>T)Unspecified-PubMed=9598804
MutationSimpleBRAFp.Val600Glu (c.1799T>A)Unspecified-PubMed=26214590

Haplotype Information (STR Profile)

Short Tandem Repeat (STR) profile for cell line authentication.

Amelogenin
X
CSF1PO
10,11
D13S317
8,11
D16S539
9,11
D5S818
11,12
D7S820
8,11
TH01
7,9.3
TPOX
8
vWA
14,20
Gene Expression Profile
Gene expression levels and statistical distribution
Loading cohorts...
Full DepMap dataset with combined data across cell lines

Loading gene expression data...

Publications

Pan-cancer proteomic map of 949 human cell lines.";

Robinson P.J., Zhong Q., Garnett M.J., Reddel R.R.

Cancer Cell 40:835-849.e8(2022).

Comprehensive transcriptomic analysis of cell lines as models of primary tumors across 22 tumor types.

van 't Veer L.J., Butte A.J., Goldstein T., Sirota M.

Nat. Commun. 10:3574.1-3574.11(2019).

Next-generation characterization of the Cancer Cell Line Encyclopedia.

Sellers W.R.

Nature 569:503-508(2019).

An interactive resource to probe genetic diversity and estimated ancestry in cancer cell lines.

Dutil J., Chen Z.-H., Monteiro A.N.A., Teer J.K., Eschrich S.A.

Cancer Res. 79:1263-1273(2019).

A landscape of pharmacogenomic interactions in cancer.";

Wessels L.F.A., Saez-Rodriguez J., McDermott U., Garnett M.J.

Cell 166:740-754(2016).

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.

Morrissey M.P., Sellers W.R., Schlegel R., Garraway L.A.

Nature 483:603-607(2012).

Genetic interaction between NRAS and BRAF mutations and PTEN/MMAC1 inactivation in melanoma.

Tsao H., Goel V., Wu H., Yang G., Haluska F.G.

J. Invest. Dermatol. 122:337-341(2004).